Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,150,889 papers from all fields of science
Search
Sign In
Create Free Account
STARD8 gene
Known as:
KIAA0189
, ARHGAP38
, DLC3
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
STARD9 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
High expression of DLC family proteins predicts better prognosis and inhibits tumor progression in NSCLC
Li Sun
,
Jing Sun
,
Jun-ding Song
Molecular Medicine Reports
2019
Corpus ID: 145820750
The incidence of primary lung cancer (PLC) is increasing and is becoming a leading cause of cancer-associated mortality worldwide…
Expand
2016
2016
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
Dunrui Wang
,
X. Qian
,
Megha Rajaram
,
M. Durkin
,
D. Lowy
OncoTarget
2016
Corpus ID: 992944
The RHO family of RAS-related GTPases in tumors may be activated by reduced levels of RHO GTPase accelerating proteins (GAPs…
Expand
2016
2016
The polarity protein Scribble positions DLC3 at adherens junctions to regulate Rho signaling
J. Hendrick
,
M. Franz‐Wachtel
,
Yvonne Moeller
,
S. Schmid
,
B. Maček
,
M. Olayioye
Development
2016
Corpus ID: 9875854
The spatial regulation of cellular Rho signaling by GAP proteins is still poorly understood. By performing mass spectrometry, we…
Expand
2015
2015
The Rho-specific GAP protein DLC3 coordinates endocytic membrane trafficking
A. Braun
,
J. Hendrick
,
Stephan A Eisler
,
S. Schmid
,
A. Hausser
,
M. Olayioye
Journal of Cell Science
2015
Corpus ID: 23900340
ABSTRACT Membrane trafficking is known to be coordinated by small GTPases, but the identity of their regulators, the guanine…
Expand
2012
2012
The RhoGAP protein Deleted in Liver Cancer 3 (DLC3) is essential for adherens junctions integrity
G. Holeiter
,
A. Bischoff
,
+6 authors
M. Olayioye
Oncogenesis
2012
Corpus ID: 16909726
Epithelial cell–cell contacts are mediated by E-cadherin interactions, which are regulated by the balanced local activity of Rho…
Expand
Review
2011
Review
2011
Deleted in liver cancer protein family in human malignancies (Review).
D. Lukasik
,
E. Wilczek
,
A. Wasiutyński
,
B. Gornicka
Oncology Letters
2011
Corpus ID: 42472747
The Deleted in Liver Cancer (DLC) protein family comprises proteins that exert their function mainly by the Rho GTPase-activating…
Expand
Highly Cited
2009
Highly Cited
2009
Distinct High-Profile Methylated Genes in Colorectal Cancer
P. Mokarram
,
Krishan Kumar
,
+7 authors
H. Ashktorab
PLoS ONE
2009
Corpus ID: 2562787
Background Mutations and promoters' methylation of a set of candidate cancer genes (CAN genes) are associated with progression of…
Expand
Highly Cited
2007
Highly Cited
2007
Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth
M. Durkin
,
V. Ullmannová
,
M. Guan
,
N. Popescu
Oncogene
2007
Corpus ID: 5867743
Two related Rho GTPase-activating proteins, DLC-1 (deleted in liver cancer 1) and DLC-2, are emerging as bona fide tumor…
Expand
2004
2004
Characterization of human ARHGAP10 gene in silico.
Masuko Katoh
,
M. Katoh
International Journal of Oncology
2004
Corpus ID: 39769244
ARHGAP family genes encode Rho/Rac/Cdc42-like GTPase activating proteins with RhoGAP domain. Here, we characterized human…
Expand
Highly Cited
1996
Highly Cited
1996
Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.
T. Nagase
,
N. Seki
,
K. Ishikawa
,
A. Tanaka
,
N. Nomura
DNA Research
1996
Corpus ID: 31039178
As part of our continuing efforts to accumulate information on the coding region of unidentified human genes, we newly determined…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE